Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. immune regulation
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Immune Regulation Articles & Analysis

13 news found

CD Genomics Launches Mature HLA Typing Solutions Enabling Precision Immune Profiling

CD Genomics Launches Mature HLA Typing Solutions Enabling Precision Immune Profiling

CD Genomics, a renowned leader in genomics and next-generation sequencing (NGS) applications, has unveiled its cutting-edge HLA typing solutions, revolutionizing immune profiling and transplantation compatibility assessment. The human leukocyte antigen (HLA) system plays a crucial role in immune regulation and determining transplantation compatibility. HLA typing, the process of identifying ...

ByCD Genomics


Creative Proteomics Cytokine Launches Growth Factors (GF) Detection Service for Your Research

Creative Proteomics Cytokine Launches Growth Factors (GF) Detection Service for Your Research

Cytokine, a subdivision of Creative Proteomics, specializes in providing cytokine research and analytical services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Recently, the product manager of the company is pleased to announce the launch of the growth factors (GF) detection service for further research enhancement. ...

ByCreative Proteomics


Elpiscience Announces Studies Presented at SITC 2022 Annual Meeting

Elpiscience Announces Studies Presented at SITC 2022 Annual Meeting

Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide, presented positive studies for its innovative immunotherapeutic molecules at the SITC 2022 Annual Meeting, including anti-SIRPα monoclonal antibody ES004, PD-L1/SIRPα bispecific antibody ...

ByElpiscience


PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022

PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022

PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022 DAEJEON, South Korea, October 17, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the Company will present preclinical data of PMC-309, one of the Company’s first immuno-oncology ...

ByPharmAbcine Inc.


Fosun Pharma and Neovii signed an agreement to exclusively sell and develop Grafalon (anti-human T cell rabbit immunoglobulin) in China

Fosun Pharma and Neovii signed an agreement to exclusively sell and develop Grafalon (anti-human T cell rabbit immunoglobulin) in China

Shanghai, China and Rapperswil, Switzerland) Shanghai Fosun Pharma (Group) Co. (“Fosun Pharma”, stock code : 600196.SH; 02196.HK) announced that Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. (“Fosun Pharmaceutical Industry”), a controlled subsidiary, signed an exclusive sales agency and development agreement with Switzerland ’s Neovii Pharmaceuticals ...

ByShanghai Fosun Pharmaceutical (Group) Co. Ltd.


Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay

Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay

The Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently launched the Mouse Cytokine Assay with high sensitivity to support research in immune responses, inflammatory ...

ByCreative Proteomics


Creative Proteomics Cytokine Unveils Tumor Necrosis Factors (TNF) Detection Service

Creative Proteomics Cytokine Unveils Tumor Necrosis Factors (TNF) Detection Service

The Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently announced the launch of the high-sensitivity Tumor Necrosis Factors (TNF) Detection Service to help with your ...

ByCreative Proteomics


Kadimastem Expands R&D Program to Include Multiple Sclerosis

Kadimastem Expands R&D Program to Include Multiple Sclerosis

Ness Ziona, Science Park, May 18, 2022 - Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing a treatment for ALS and a potential cure for diabetes, is expanding its R&D activity with the exploration of developing a treatment for Multiple Sclerosis (MS). As part of this initiative, the company has signed a service agreement with Hadasit Medical Research Services ...

ByKadimastem Ltd.


Journal Publication: CHI3L1 regulates PD-L1 and anti–CHI3L1–PD-1 antibody elicits synergistic antitumor responses.

Journal Publication: CHI3L1 regulates PD-L1 and anti–CHI3L1–PD-1 antibody elicits synergistic antitumor responses.

“Master Pathway” Discovery. Congratulations to our Founder and Scientific Advisory Board Chairman, Dr. Jack A. Elias, on the publication of his breakthrough lung cancer research in the Journal of Clinical Investigation. Referring to the important role played by CHI3L1 in lung cancer metastasis in the accompanying authors note, Dr. Elias says, “We believe we have discovered a ...

ByOcean Biomedical


New, late-breaking data at EADV highlights emerging clinical profile of amlitelimab (formerly KY1005) in adults with inadequately controlled moderate-to-severe atopic dermatitis

New, late-breaking data at EADV highlights emerging clinical profile of amlitelimab (formerly KY1005) in adults with inadequately controlled moderate-to-severe atopic dermatitis

Low dose arm of the study met the co-primary endpoints of percent change in Eczema Area and Severity Index (EASI) score from baseline, and incidence of treatment-emergent adverse events, through week 16 First trial to assess the effects of blocking OX40-Ligand, a key immune system regulator, in patients with moderate-to-severe atopic dermatitis Data support amlitelimab as a potential ...

ByKiadis Pharma NV


Creative Enzymes Launches Anti Helicobacter Pylori Formula for Academic and Industrial Use

Creative Enzymes Launches Anti Helicobacter Pylori Formula for Academic and Industrial Use

Creative Enzymes is a professional enzyme provider located in New York, USA. With the continuous expansion of business areas and scale, they have set foot in other areas and established a sound probiotic production and supply chain. Based on high-quality products and services, as well as the unique advantages of large-scale production, its probiotic products are widely favored by industrial ...

ByCreative Enzymes


Strong antioxidant `bilirubin` to be developed as a disease treatment for the first time

Strong antioxidant `bilirubin` to be developed as a disease treatment for the first time

“We will make ‘bilirubin,’ a substance with antioxidant effects that removes harmful free radicals, as a disease treatment for the first time in the world.” “Over 20,000 papers since 1987 have shown that bilirubin has a therapeutic effect on various diseases,” said Myung-Lip Kim, CEO of Bilix, a bio company developing new drugs that we met last week at the ...

ByBilix Co., Ltd.


New Study:  Infant Gut Health Must Focus on Microbiome Function, Not Diversity

New Study: Infant Gut Health Must Focus on Microbiome Function, Not Diversity

The concepts of ecology, conservation, and restoration typically conjure images of natural woodlands, water systems and air quality. However, a new peer-reviewed perspective by Evolve BioSystems is taking a page from ecology playbooks in an effort to assist neonatologists and other pediatric health care professionals in assessing the state of the infant gut microbiome, which plays a significant ...

ByEvolve BioSystems, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT